Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 156.80 1.69
Tata Stl 459.30 1.55
Axis Ban 377.80 2.18
H D F C 871.00 0.79
Bhel 200.95 2.85
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Shilpa Medicare Limited
Shilpa Medicare Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530549NSE:SHILPAMEDBloomberg:SLPA@INReuters:SHME.BO
Market Lot: 1Face Value: 2ISIN Demat: INE790G01023
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
27-JUN-13 Shilpa Medicare (SML) said on Thursday that it has signed an agreement with The United Nations-backed Medicines Patent Pool (MPP) and Gilead Sciences to increase access to medicines for HIV/AIDS treatment. 12-JUN-13 Shilpa Medicare announced that its state of art facility at Pharma Park Jadcherla (SEZ), near Mahaboobnagar (AP) for undertaking contract research & forward integration i.e. own formulation`(manufacturing of oral & inject...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Shilpa Medicare signs pact UN for HIV/AIDS drugs  -IRIS 27-Jun-13
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1267.265273.683281.96
Other Income14.6088.5350.06
Total Income1281.865362.213332.02
Cost of goods sold960.154096.502633.73
OPBDIT321.711265.71698.29
PAT190.35808.57459.60
Gross Block---
Equity capital77.1073.5749.05
EPS (Rs.)-21.9818.74
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-6.19 - 19.2511.10 - 17.52
Debt / Equity (x)---
Operating margin (% of OI)25.123.621.0
Net margin (% of OI)14.815.113.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
1st Floor, 10/ 80
Rajendra Gunj
Raichur
Karnataka-584 102
PHONE
(08532) 2350 06/ 2357 04
FAX
(08532) 2358 76
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | E-mail | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer